Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma

Abstract Background Hepatitis B virus (HBV) is the major risk factor for hepatocellular carcinoma (HCC). The molecular mechanisms underlying HBV-associated HCC pathogenesis is still unclear. Genetic alterations in cancer-related genes have been linked to many human cancers. Here, we aimed to explore...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Fung-Yu Huang, Danny Ka-Ho Wong, Vivien Wai-Man Tsui, Wai-Kay Seto, Lung-Yi Mak, Tan-To Cheung, Keane K.-Y. Lai, Man-Fung Yuen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2019-08-01
Sarja:BMC Cancer
Aiheet:
Hepatocellular carcinoma
Targeted sequencing
Deleterious mutations
Customized therapies
Gene silencing
Linkit:http://link.springer.com/article/10.1186/s12885-019-6002-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia